» Articles » PMID: 1972637

Evidence for the Presence of N-methyl-D-aspartate Receptors in the Ventral Tegmental Area of the Rat: an Electrophysiological in Vitro Study

Overview
Journal Brain Res
Specialty Neurology
Date 1990 Apr 23
PMID 1972637
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular recordings were obtained from spontaneously active, presumed dopaminergic neurons of the ventral tegmental area (VTA) of the rat in a slice preparation. Bath-applied N-methyl-D-aspartate (NMDA) (1-20 microM) activated all neurons tested (n = 36). This effect was clearly concentration-dependent (n = 14), quickly reversible and reproducible. No bursting type of discharge was observed during NMDA infusion. The NMDA receptor blocker DL-2-amino-5-phosphonovaleric acid (50 microM) reversibly antagonized the increase in cell firing produced with 10 microM NMDA by 83.5 +/- 3% (mean +/- S.E.M.) (n = 8, P less than 0.05). Lowering the Mg2+ concentration of the perfusion fluid to one-third of its normal value significantly enhanced the excitatory effect of 5 microM NMDA (n = 7, P less than 0.05), but not of 500 nM carbachol (n = 6). Finally, NMDA did not modify the sensitivity of dopaminergic autoreceptors of VTA neurons (n = 8), when compared to controls (n = 10). These observations strongly support the presence of specific NMDA receptors in the VTA.

Citing Articles

Prenatal nicotine alters development of the laterodorsal tegmentum: Possible role for attention-deficit/hyperactivity disorder and drug dependence.

Polli F, Kohlmeier K World J Psychiatry. 2022; 12(2):212-235.

PMID: 35317337 PMC: 8900586. DOI: 10.5498/wjp.v12.i2.212.


D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine.

Betts J, Schweimer J, Burnham K, Burnet P, Sharp T, Harrison P Front Synaptic Neurosci. 2014; 6:11.

PMID: 24822045 PMC: 4014674. DOI: 10.3389/fnsyn.2014.00011.


Opposite modulation of brain stimulation reward by NMDA and AMPA receptors in the ventral tegmental area.

Ducrot C, Fortier E, Bouchard C, Rompre P Front Syst Neurosci. 2013; 7:57.

PMID: 24106463 PMC: 3789217. DOI: 10.3389/fnsys.2013.00057.


Developmental pathology, dopamine, stress and schizophrenia.

Lodge D, Grace A Int J Dev Neurosci. 2010; 29(3):207-13.

PMID: 20727962 PMC: 3022957. DOI: 10.1016/j.ijdevneu.2010.08.002.


Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.

Alex K, Pehek E Pharmacol Ther. 2006; 113(2):296-320.

PMID: 17049611 PMC: 2562467. DOI: 10.1016/j.pharmthera.2006.08.004.